Skip to main content
. 2000 Dec 15;20(24):9333–9340. doi: 10.1523/JNEUROSCI.20-24-09333.2000

Table 4.

DAT immunoreactivity in the Acb and dorsal STR 3 d after a 5 d treatment with cocaine and/or the selective κ-opioid receptor agonist U-69593

Treatment Acb Dorsal STR n
U-69593 112  ± 11 95  ± 3 6
Cocaine 132  ± 22 129  ± 14 6
Vehicle + U-69593 186  ± 304-150 112  ± 13 6

Data expressed as percentage of control immunoreactivity ± SEM.

F4-150: p < 0.05 different from controls by one-way ANOVA.